Header Logo

Connection

MILIND JAVLE to Alopecia

Back to Details
This is a "connection" page, showing publications MILIND JAVLE has written about Alopecia.
MILIND JAVLE
Connection Strength
0.192
Alopecia
  1. Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study. Lancet Gastroenterol Hepatol. 2021 10; 6(10):803-815.
    View in: PubMed
    Score: 0.192
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.